CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	3 Months Ended		9 Months Ended		16 Months Ended
	Sep. 26, 2015	Sep. 27, 2014	Sep. 26, 2015	Sep. 27, 2014	Sep. 26, 2015
Cash flows from operating activities:
Net earnings	$ 13,549	$ 25,285	$ 74,495	$ 147,700
Adjustments to reconcile net earnings to net cash flows from operations:
Depreciation and amortization			70,859	64,460
Noncash loss on trading securities			5,020	4,859
Impairment of assets - restructuring activities			12,659	0
Impairment of goodwill & intangible assets			15,200	0
Non-cash debt refinancing costs			0	(2,478)
Stock-based compensation			5,667	5,444
Change in fair value of contingent consideration			0	4,300
Defined benefit pension plan expense (benefit)			(460)	2,003
Contribution to defined benefit pension plan			(15,735)	(18,245)
Gain on sale of property, plant and equipment			1,263	58
Equity in earnings in nonconsolidated subsidiaries	0	4	0	34
Deferred income taxes	5,272	(9,064)	5,217	(4,034)
Changes in assets and liabilities (net of acquisitions):
Receivables			5,551	(19,951)
Inventories			(25,447)	(4,152)
Prepaid expenses			5,275	(19,182)
Accounts payable			832	(21,082)
Accrued expenses			7,368	(27,926)
Other noncurrent liabilities			887	(6,409)
Income taxes refundable			14,171	(22,702)
Net cash flows from operating activities			182,822	82,697
Cash flows from investing activities:
Purchase of property, plant and equipment			(34,447)	(63,412)
Proceeds from sale of assets			3,256	2,107
Acquisitions, net of cash acquired			0	(137,438)
Other, net			5,980	2,992
Net cash flows from investing activities			(25,211)	(195,751)
Cash flows from financing activities:
Net borrowings under short-term agreements			(12,322)	(1,065)
Proceeds from long-term borrowings			37,000	652,540
Principal payments on long-term borrowings			(37,878)	(357,059)
Settlement of financial derivatives			0	4,837
Dividends paid			(26,708)	(23,357)
Dividends to noncontrolling interest			(2,323)	(1,340)
Debt issuance costs			0	(5,464)
Purchase of treasury shares			(148,220)	(316,296)	$ (543,300)
Proceeds from exercises under stock plans			10,902	12,824
Excess tax benefits from stock option exercises			1,458	3,916
Purchase of common treasury shares—stock plan exercises			(12,135)	(12,739)
Net cash flows from financing activities			(190,226)	(43,203)
Effect of exchange rate changes on cash and cash equivalents			(26,113)	(5,231)
Net change in cash and cash equivalents			(58,728)	(161,488)
Cash and cash equivalents—beginning of year			371,579	613,706
Cash and cash equivalents—end of period	$ 312,851	$ 452,218	$ 312,851	$ 452,218	$ 312,851